IL6 and chronic kidney disease: Elevated levels of interleukin-1 (IL-1), interleukin-6 (IL-IL6), and other inflammatory markers in patients with CKD activate the inflammatory cascade, exacerbating renal damage and promoting renal fibrosis (29–31).